Robot-assisted pyeloplasty for ureteropelvic junction obstruction: initial experience with the novel avatera system

Evaluation of Clinical Research on Novel Multiport Robotic Platforms for Urological Surgery According to the IDEAL Framework: A Systematic Review of the Literature

“…The remaining 59 studies included in our systematic review were noncomparative surgical series or case reports [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , [69] , [70] , [71] , [72] , [73] , [74] , [75] , [76] , [77] , [78] , [79] , [80] , [81] , [82] , [83] , [84] , [85] , [86] , [87] , [88] .…”

“…Two studies reporting clinical data on the Avatera robotic system were included in our review [86] , [87] ( Table 7 ). In 2023, Kallidonis et al [86] published results from the first human clinical study and reported on the surgical technique and clinical data for nine patients who underwent robot-assisted pyeloplasty (stage 1–2a). Gkeka et al [87] described perioperative outcomes for 14 consecutive RARP cases performed with the Avatera system (stage 1–2a).…”